---
title: Medical Radiometer - RTM - 01 - RES and Its Use in Detecting Hotspots in Female Breast
nct_id: NCT02286583
overall_status: UNKNOWN
phase: NA
sponsor: Labdom Suisse
study_type: INTERVENTIONAL
primary_condition: Breast Cancer
countries: Malaysia
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02286583.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02286583"
ct_last_update_post_date: 2015-04-01
last_seen_at: "2026-05-12T06:20:09.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Medical Radiometer - RTM - 01 - RES and Its Use in Detecting Hotspots in Female Breast

**Official Title:** Early Detection of Breast Disease Using Medical Radiometer - RTM - 01 - RES

**NCT ID:** [NCT02286583](https://clinicaltrials.gov/study/NCT02286583)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 2000
- **Lead Sponsor:** Labdom Suisse
- **Conditions:** Breast Cancer
- **Start Date:** 2015-02
- **Completion Date:** 2015-10
- **CT.gov Last Update:** 2015-04-01

## Brief Summary

Medical Radiometer depends on detecting the microwaves that radiates from deep structure hot objects in the body. When it comes to the breast, causes of deep structure hot spots are numerous, it can be inflammatory, hormonal or neoplastic. Therefore, the primary objective of this study is to test the sensitivity of the Medical Radiometer in detecting the hot spots in the breast.

## Detailed Description

Several pathological lesions and physiological changes can cause spot in the breast to show higher temperature than it should be.

The causes can be:

\[I\] Physiological: During menarch, puberty, menstruation, lactation and after sexual Intercourse.

\[II\] Inflammatory: Mastitis and breast Abscess. \[III\] Endocrinal: any cause of increasing Oestrogen, Prolactin and/or Thyroid hormones.

\[IV\] Neoplastic: the neo-Vascularisation of the malignant tumors. Radiometer is a machine that can detect through its sensitive probe the microwave that radiate from the deep structures in the body.

The main aim of this study, first is to measure the sensitivity of the RTM in detecting the hot spots of different breast lesions.

The second Objective is to study the temperature patter of each disease trying to figure out a diagnostic code for the different lesions.

The tertiary objective is to combine the Echo-Dobbler in studying the hot spots in the neoplastic lesions trying to figure out an accurate protocol to early detect the malignant hot spots.

## Eligibility

- **Sex:** FEMALE
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* The perfect sample should be 2000 females or more.
* 50 % already diagnosed breast cancer of any type
* 30% normal thought to be healthy females.
* 10% lactating
* 10% different breast diseases

Exclusion Criteria:

* Menstruating females.
```

## Arms

- **Microwave Thermography RTM-01-RES** (NO_INTERVENTION) — Microwave thermography with sensitive probe that can detect skin and up to 8 cm microwave radiation deep tissues

## Interventions

- **Microwave Thermography RTM-01-RES** (DEVICE) — Divide the breast into 3 circles start from the nipple with 1 cm increase in the circle diameter. Divide this circle into 8 points. This makes us detect 24 points in addition to the nipple as fixed point and the tail of the breast as separate point giving total of 26 points.

## Primary Outcomes

- **Testing the sensitivity of the Microwave Thermography RTM-01-RES (ability to detect hotspots in breast lesions)** _(time frame: 6 months)_ — Ability of the Microwave Thermography RTM-01-RES to detect hotspots in the various breast lesions.

## Secondary Outcomes

- **Study the Temperature pattern** _(time frame: 3 months)_

## Locations (1)

- Poliklinik Permai Tanjumg Aru, Kota Kinabalu, Sabah, Malaysia — _RECRUITING_

## Recent Field Changes (last 30 days)

- `locations.poliklinik permai tanjumg aru|kota kinabalu|sabah|malaysia` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02286583.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02286583*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*